Trademark: 97220299
Word
DIAMOND
Status
Dead
Status Code
602
Status Date
Saturday, April 1, 2023
Serial Number
97220299
Mark Type
4000
Filing Date
Friday, January 14, 2022
Abandoned Date
Wednesday, March 15, 2023

Trademark Owner History

Classifications
5 Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders
42 Software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for data analysis in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; scientific research, namely, research and analysis services featuring artificial intelligence and machine learning analytics in the fields of healthcare, biomedical and genomic research; research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; research and development of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials

Trademark Events
Apr 3, 2023
Abandonment Notice E-Mailed - Failure To Respond
Apr 1, 2023
Abandonment Notice Mailed - Failure To Respond
Apr 1, 2023
Abandonment - Failure To Respond Or Late Response
Sep 14, 2022
Notification Of Non-Final Action E-Mailed
Sep 14, 2022
Non-Final Action E-Mailed
Sep 14, 2022
Non-Final Action Written
Aug 18, 2022
Teas/Email Correspondence Entered
Aug 17, 2022
Correspondence Received In Law Office
Aug 17, 2022
Teas Response To Office Action Received
Jul 8, 2022
Notification Of Non-Final Action E-Mailed
Jul 8, 2022
Non-Final Action E-Mailed
Jul 8, 2022
Non-Final Action Written
Jul 5, 2022
Assigned To Examiner
Jan 21, 2022
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24